Submission Details
| 510(k) Number | K220483 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 18, 2022 |
| Decision Date | September 23, 2022 |
| Days to Decision | 217 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K220483 is an FDA 510(k) clearance for the Platform? Acetabular System, a Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented (Class II — Special Controls, product code LZO), submitted by Total Joint Orthopedics, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on September 23, 2022, 217 days after receiving the submission on February 18, 2022. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3353.
| 510(k) Number | K220483 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 18, 2022 |
| Decision Date | September 23, 2022 |
| Days to Decision | 217 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | LZO — Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3353 |